Strategic Partnerships SMART Medical Systems has a history of collaboration with major players like FUJIFILM and ongoing clinical partnerships with NYU Langone Health, indicating strong potential to leverage co-development, distribution, and joint marketing opportunities to expand adoption of G-EYE and NaviAid technologies in new markets.

Regulatory & Compliance With ISO 13485 certification and FDA clearance plus CE Mark, the company demonstrates solid regulatory readiness, creating opportunities to pitch scalable, compliant endoscopy solutions to hospitals and clinics seeking proven, internationally recognized devices with smoother procurement.

US Market Access The presence of a wholly-owned US subsidiary and prior expansion efforts suggest a ready platform to accelerate sales in the United States, targeting endoscopy centers and GI departments with bundled offerings that highlight improved detection and cost-effectiveness.

Clinical & Economic Value G-EYE and balloon-assisted technology aim to increase polyp detection and procedural efficiency, creating conversations around clinical outcomes, reduced procedure times, and potential cost savings—key hooks for procurement and payer discussions.

Growth Readiness Recent milestones in 2021–2022 with FDA clearance and alliance with Fujifilm, plus a focused leadership and commercialization push in the US, position SMART as a scalable partner for distributors and hospital networks seeking innovative endoscopy solutions.